Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis.

MLA

Sborgia, Giancarlo, et al. “Mid-Term Safety and Effectiveness of Intravitreal Dexamethasone Implant to Treat Persistent Cystoid Macular Edema in Vitrectomized Eyes for Bacterial Endophthalmitis.” Graefe’s Archive of Clinical & Experimental Ophthalmology, vol. 260, no. 8, Aug. 2022, pp. 2703–10. EBSCOhost, https://doi.org/10.1007/s00417-022-05615-8.

APA

Sborgia, G., Niro, A., Pastore, V., Favale, R. A., Sborgia, A., Gigliola, S., Giuliani, G., Grassi, M. O., Coassin, M., Aiello, F., Iaculli, C., Reibaldi, M., Boscia, F., & Alessio, G. (2022). Mid-term safety and effectiveness of intravitreal dexamethasone implant to treat persistent cystoid macular edema in vitrectomized eyes for bacterial endophthalmitis. Graefe’s Archive of Clinical & Experimental Ophthalmology, 260(8), 2703–2710. https://doi.org/10.1007/s00417-022-05615-8

Chicago

Sborgia, Giancarlo, Alfredo Niro, Valentina Pastore, Rosa Anna Favale, Alessandra Sborgia, Samuele Gigliola, Gianluigi Giuliani, et al. 2022. “Mid-Term Safety and Effectiveness of Intravitreal Dexamethasone Implant to Treat Persistent Cystoid Macular Edema in Vitrectomized Eyes for Bacterial Endophthalmitis.” Graefe’s Archive of Clinical & Experimental Ophthalmology 260 (8): 2703–10. doi:10.1007/s00417-022-05615-8.